- OncoSec's And Ziopharm's IL-12 Targeted Delivery Systems: Which Will Succeed?
- Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical
- Potential DelMar Investors Await First 10Q Filings From The Sidelines
- 2 Medical Device Companies With Revolutionary Platforms
- Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In 2013
Chemistfrog
ABOUT
I'm a small-time writer who dreams big and enjoys reading and writing about biotechs and pharmaceuticals. I also enjoy dabbling with penny stocks but keep my exposure there limited. My work experiences include food safety, water quality, pesticides, food additives, paints, plastics and pharmaceutical precursors. My focus as of late has been researching the immunotherapy approach to treating many cancers and prevention of their recurrence. More recent research has been in the stem cell field, an exciting field in its infancy but now becoming a teenager! My ongoing goal for investors is attempting to find under-the-radar or oversold pharmaceuticals or biotechs for investment potential.
Please feel free to add me ...More
Please feel free to add me ...More
SNAPSHOT
- Description: Full time investor. Trading frequency: Weekly
- Interests: ETFs, Energy stocks, Mutual funds, Options, Retirement savings, Stocks - long, Stocks - short, Tech stocks
COMPANY
BLOG
Chemistfrog Blog, Stock Picks, Alerts and Company Due Diligence!!
Thanks for an exciting 2013! Please feel free to sign up for my free newsletter/alerts. If I have no solid investment candidates, I send nothing. No pumping, only information to be used for your own continued due diligence.
Book
Currently, there are no book details for Chemistfrog.
LATEST STOCKTALK
more »
Been buying safer stocks as of late. Work is too busy to babysit volatile pennies except for very small positions.
May 22, 2013
Latest Comments
more »
Latest comments on Chemistfrog's Articles
LATEST ARTICLES & INSTAPOSTS
more »